*Some Market data delayed by 15 mins.

Mustang Bio, Inc.

Symbol: MBIO (NASDAQ)
0.35 ▼ (-5.60%) -0.021

Company Description:
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

Key Stats
  • Today's Open: $0.3701
  • Today's High: $0.398
  • Today's Low: $0.325
  • Today's Volume: 2.81M
  • Yesterday Close: $0.3676
  • Yesterday High: $0.403
  • Yesterday Low: $0.3633
  • Yesterday Volume: 2.04M
  • Last Min Volume: 86
  • Last Min High: $0.347
  • Last Min Low: $0.347
  • Last Min VWAP: $0.347
Company Profile
  • Name: Mustang Bio, Inc.
  • Website: https://www.mustangbio.com
  • Listed Date: 2017-08-22
  • Location: WORCESTER, MA
  • Market Status: Active
  • CIK Number: 0001680048
  • SIC Code: 2834
  • SIC description: PHARMACEUTICAL PREPARATIONS
  • Market Cap: $10.97M
  • Round Lot: 100
  • Outstanding Shares: 32.26M
  • Asset Type: CS
RECENT FILINGS FOR MBIO
Filing DateFiling TypeFormat
2024-07-10DEF 14CView
2024-07-038-KView
2024-07-03424B5View
2024-06-28PRE 14CView
2024-06-28SC 13D/AView
2024-06-284View
2024-06-24DView
2024-06-248-KView
2024-06-21424B5View
2024-06-20424B5View
2024-06-12EFFECTView
2024-06-10CORRESPView
2024-06-068-KView
2024-06-044View
2024-06-044View
2024-06-04UPLOADView
2024-05-31S-3View
2024-05-218-KView
2024-05-1510-QView
2024-05-13424B3View
Latest News

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.